Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines

Vaccine

Volumn 17, Issue 19, 1999, Pages 2423-2428

  Kairo, Satnam K ^a   Bedwell, Joanne ^a   Tyler, Paul C ^a   Carter, Anne ^a   Corbel, Michael J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

BCG viability; Control; Tetrazolium salts

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULPHENYL) (2H) TETRAZOLIUM 5 CARBOXANILIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BCG VACCINE; DIAGNOSTIC AGENT; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; BCG VACCINATION; CELL VIABILITY; COLONY FORMING UNIT; DRUG DETERMINATION; DRUG POTENCY; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; REPRODUCIBILITY; STANDARDIZATION;

BCG VACCINE; CELL COUNT; COLONY-FORMING UNITS ASSAY; COLORING AGENTS; FREEZE DRYING; INDICATORS AND REAGENTS; MYCOBACTERIUM BOVIS; TETRAZOLIUM SALTS; THIAZOLES; VACCINES, ATTENUATED;

EID: 0033553659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00023-7     Document Type: Article

References (23)

1. European Pharmacopoeia Commission. Freeze-dried BCG vaccine. In: Council of Europe, editors. European Pharmacopoeia. Strasbourg, 1997, p. 442-443.
2. Donikian R., Gheorghiu M., Jablokova T.B. Requirements for dried BCG vaccine. WHO Technical Report Series. 745:1987;60-92.
3. Milstien J.B., Gibson J.J. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull. World Health Organ. 68:1990;93-108.
4. Borremans M., Weckx M., Verhofstadt R. A comparison of the rate of oxygen uptake and the adenosine triphosphate content of routine and experimental BCG preparations. J. Biol. Stand. 11:1983;205-212.
5. Chen Z.R., Cheng S.G., An Y.Q., Cao X.H. Experimental research on utilization of bioluminescent technique to substitute the current viability count for BCG vaccine. Chin. Med. J. Engl. 102:1989;906-910.
6. Shi M.F., Klegerman M.E., Groves M.J. Viability of freeze-dried Tice-substrain BCG by bioluminescent measurement of adenosine triphosphate. Microbios. 59:1989;145-155.
7. Askgaard D.S., Gottschau A., Knudsen K., Bennedsen J. Firefly luciferase assay of adenosine triphosphate as a tool of quantitation of the viability of BCG vaccines. Biologicals. 23:1995;55-60.
8. Gomez Flores R., Gupta S., Tamez Guerra R., Mehta R.T. Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J. Clin. Microbiol. 33:1995;1842-1846.
9. Franzblau S.G., Witzig R.S., McLaughlin J.C., Torres P., Madico G., Hernandez A., Degnan M.T., Cook M.B., Quenzer V.K., Ferguson R.M., Gilman R.H. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:1998;362-366.
10. Mshana R.N., Tadesse G., Abate G., Miorner H Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 36:1998;1214-1219.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
12. Roehm N.W., Rodgers G.H., Hatfield S.M., Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods. 142:1991;257-265.
13. Sladowski D., Steer S.J., Clothier R.H., Balls M. An improved MTT assay. J. Immunol. Methods. 157:1993;203-207.
14. Peck R. A one-plate assay for macrophage bactericidal activity. J. Immunol. Methods. 82:1985;131-140.
15. Stevens M.G., Olsen S.C. Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J. Immunol. Methods. 157:1993;225-231.
16. Urban T., Jarstrand C. Nitroblue tetrazolium (NBT) reduction by bacteria. Some properties of the reaction and its possible use. Acta Pathol. Microbiol. Scand. B. 87:1979;227-233.
17. Thom S.M., Horobin R.W., Seidler E., Barer M.R. Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J. Appl. Bacteriol. 74:1993;433-443.
18. Cesari I.M., Rieber M., Imaeda T. Localization and properties of enzymes involved with electron transport activity in mycobacteria. J. Bacteriol. 98:1969;767-773.
19. Meshulam T., Levitz S.M., Christin L., Diamond R.D. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 172:1995;1153-1156.
20. Bartlett R.C., Mazens M., Greenfield B. Acceleration of tetrazolium reduction by bacteria. J. Clin. Microbiol. 3:1976;327-329.
21. Gaines R.E., Tydeman M.S. Iterative weighted regression analysis of logit responses: a computer program for analysis of bioassays and immunoassays. Comput. Programs Biomed. 15:1982;13-21.
22. Niks M., Otto M. Towards an optimized MTT assay. J. Immunol. Methods. 130:1990;149-151.
23. Berridge M.V., Tan A.S., McCoy K.D., Wang R. The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica. 4:1996;15-20.